Published in J Clin Invest on August 01, 1978
Immunoglobulin D: properties, measurement, and clinical relevance. Clin Diagn Lab Immunol (2000) 0.82
IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol (1975) 4.92
Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN. J Exp Med (1965) 3.42
Immunoglobulin-receptors revisited. Science (1975) 3.38
A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD. J Exp Med (1965) 3.31
Communications. IgD-bearing human lymphocytes. J Immunol (1972) 2.17
The molecular genetics of mammalian glucuronidase. J Cell Physiol (1975) 2.16
Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet (1977) 1.94
Structural studies of human gamma D myeloma protein. Biochemistry (1970) 1.66
Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. Acta Pathol Microbiol Scand (1968) 1.51
Inheritance of very low serum dopamine-beta-hydroxylase activity. Am J Hum Genet (1975) 1.40
Immunoglobulin D in serum, body fluids and lymphoid tissues. Clin Exp Immunol (1968) 1.34
B-cell tolerance. III. Effect of papain-mediated cleavage of cell surface IgD on tolerance susceptibility of murine B cells. J Exp Med (1977) 1.32
The influence of heredity and environment on human immunoglobulin levels. J Immunol (1969) 1.25
Antigen combining activity associated with immunoglobulin D. Science (1969) 1.04
The correlation of serum IgD concentration with Gm allotype. J Immunol (1974) 1.00
Measurement of IgD by a double antibody radioimmunoassay: demonstration of an apparent trimodal distribution of IgD levels in normal human sera. J Immunol (1977) 0.99
Quantitative comparison of immunoglobulins in atopic (reaginic) and nonatopic (nonreaginic) individuals: higher gamma-D levels in atopic sera. J Allergy (1967) 0.96
A study of antibody responses by radioimmunodiffusion with demonstration of gamma D antigen-binding activity in four sera. J Immunol (1970) 0.94
The fragmentation of human IgD during storage. Clin Chim Acta (1967) 0.94
Proteolytic degradation of IgD and its relation to molecular conformation. J Biol Chem (1972) 0.93
Serum immunoglobulins in healthy children and adults. Levels of the five classes, expressed in international units per millilitre. Clin Chim Acta (1975) 0.92
Serum IgD concentration in pregnant women. Clin Immunol Immunopathol (1975) 0.78
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics (1996) 6.83
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
The eosinophilic leukocyte: structure and function. Adv Immunol (1986) 4.08
Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet (1980) 3.71
Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med (1971) 3.47
Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res (1988) 3.47
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev (1992) 3.42
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet (1990) 3.38
Cytotoxic properties of the eosinophil major basic protein. J Immunol (1979) 3.29
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med (1990) 3.05
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest (1980) 2.70
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc (1992) 2.64
Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther (1989) 2.51
The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol (1986) 2.29
Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet (1982) 2.21
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction. Gastroenterology (1999) 2.14
Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis (1989) 2.08
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med (1990) 2.05
Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96
Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet (1977) 1.94
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A (1999) 1.90
Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med (1973) 1.87
Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85
Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc (1981) 1.85
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med (1989) 1.83
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta (1978) 1.81
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med (1990) 1.80
Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med (1985) 1.79
Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc (1997) 1.78
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77
Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther (2010) 1.74
Production of human immunoglobulin E antibody in vitro. J Immunol (1979) 1.73
Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem (1994) 1.69
Eosinophils 1992. Immunol Today (1992) 1.69
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Proportional release of norepinephrine and dopamine- -hydroxylase from sympathetic nerves. Science (1971) 1.68
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A (1986) 1.67
Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol (1986) 1.65
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64
Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun (1997) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther (1987) 1.62
Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science (1979) 1.62
Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med (1974) 1.61
Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids. J Lab Clin Med (1973) 1.61
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol (1991) 1.60
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest (1991) 1.60
Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59
Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med (1994) 1.58
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol (1992) 1.58
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology (1999) 1.54
The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol (1982) 1.53
Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest (1993) 1.53
Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry (2004) 1.53
Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis (1988) 1.52
Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy (1993) 1.52
Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol (1997) 1.52
Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics (2000) 1.51
Antibody formation in dysgammaglobulinemia. J Clin Invest (1966) 1.50
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48
Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol (2000) 1.47
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest (1981) 1.46
Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies. Pharmacogenetics (2001) 1.46
Regulatory effect of cytokines on eosinophil degranulation. J Immunol (1990) 1.45
Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol (1982) 1.45
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45
Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol (1994) 1.44
Anaphylactic transfusion reactions associated with anti-IgA antibody. N Engl J Med (1969) 1.44
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Removal of bronchoalveolar cells augments the late eosinophilic response to segmental allergen challenge. Clin Exp Allergy (2002) 1.41
Eosinophilic endomyocardial disease presenting as cyanosis, platypnea, and orthodeoxia. Ann Intern Med (1992) 1.41
Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol (2001) 1.40
Inheritance of very low serum dopamine-beta-hydroxylase activity. Am J Hum Genet (1975) 1.40
The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol (1994) 1.38
Episodic angioedema associated with eosinophilia. N Engl J Med (1984) 1.38
Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. Am J Trop Med Hyg (1979) 1.37
Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol (1983) 1.36
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol (1984) 1.35
Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chim Acta (1980) 1.34
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis. Arthritis Rheum (1975) 1.34
Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest (1997) 1.33
Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis (1985) 1.32
SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet (2009) 1.32
Serum dopamine beta-hydroxylase. Pharmacol Rev (1978) 1.31
Formation of Charcot-Leyden crystals by human basophils. J Exp Med (1982) 1.30
Low molecular weight IgM in human sera. J Lab Clin Med (1969) 1.30
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg (1985) 1.29
Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol (1991) 1.29